Agenus (AGEN) Treasury Shares (2010 - 2026)

Agenus (AGEN) posted quarterly Treasury Shares of $12881.0 for Q2 2016, down 96.03% quarter-over-quarter from $324792.0 in Q4 2013.

Agenus (AGEN) Treasury Shares (2010 - 2026) Analysis & Trends

Agenus' Treasury Shares history runs 5 years deep, the most recent figure standing at $12881.0 for Q2 2016.

In Q2 2016, Treasury Shares changed N/A year-over-year to $12881.0; the TTM figure through Jun 2016 stood at $12881.0 (changed N/A YoY), while the FY2013 annual figure was $324792.0, changed 0.0% from the prior year.
Treasury Shares for Q2 2016 stood at $12881.0, down from $324792.0 in the prior quarter.
The five-year high for Treasury Shares was $2.5 million in Q1 2023, with the low at $13595.0 in Q1 2026.
The 5-year median for Treasury Shares is $44115.0 (2025), against an average of $389425.2.
The sharpest annual moves came in 2012 and 2013: Treasury Shares changed 0.0% in 2012, then plunged 200.0% in 2013.
Agenus' Treasury Shares stood at $324792.0 in 2012, then changed by 0.0% to $324792.0 in 2013, then slumped by 96.03% to $12881.0 in 2016.
Business Quant data shows AGEN's Treasury Shares at $12881.0 in Q2 2016, $324792.0 in Q4 2013, and -$324792.0 in Q3 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Agenus	311.95 Mn	286.43 Mn	34.52 Mn	10,601.00

Download Data